pravastatin has been researched along with Brain Ischemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dailler, F; Mazard, T; Ritzenthaler, T | 1 |
| Isaka, Y; Nakamura, T; Nakayama, S; Taguchi, N; Tanaka, M | 1 |
| Aoki, S; Hosomi, N; Kagimura, T; Kamiyama, K; Kitagawa, K; Koga, M; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nezu, T; Ohtsuki, T; Origasa, H; Suzuki, R; Toyoda, K; Uchiyama, S; Yasaka, M | 1 |
| Guth, J; Kosteva, A; Levasseur-Franklin, KE; Liotta, E; Lizza, BD; Maas, MB; Naidech, AM; Rosenberg, NF | 1 |
| Beretta, S; Cai, R; Carone, D; Cattalini, A; Conti, E; Cuccione, E; de Curtis, M; Ferrarese, C; Librizzi, L; Monza, L; Sala, G; Versace, A | 1 |
| Aoki, S; Fukushima, M; Hosomi, N; Ibayashi, S; Kitagawa, K; Kohriyama, T; Maruyama, H; Matsumoto, M; Minematsu, K; Mori, E; Nagai, Y; Nakamura, M; Nezu, T; Ohtsuki, T; Origasa, H; Shinohara, Y; Sunami, N; Takagi, M; Terayama, Y; Uchiyama, S; Yamaguchi, T; Yokota, C | 1 |
| Hosomi, N; Kagimura, T; Kitagawa, K; Matsumoto, M; Minematsu, K; Nagai, Y; Nakamura, M; Ohtsuki, T; Origasa, H; Uchiyama, S | 1 |
| Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M | 1 |
| Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M | 1 |
| Blauw, GJ; Bollen, EL; de Craen, AJ; Ford, I; ten Dam, VH; van Buchem, MA; van den Heuvel, DM; Westendorp, RG | 1 |
| Carod-Artal, FJ | 1 |
| Chen, B; Zheng, Z | 1 |
| Hori, M; Kitagawa, K; Ohyama, N; Sasaki, T; Sugiura, S; Terasaki, Y; Todo, K; Yagita, Y | 1 |
| Berger, C; Maurer, MH; Schwab, S; Xia, F | 1 |
| Czosnyka, M; Hutchinson, PJ; Kirkpatrick, PJ; Pickard, JD; Richards, H; Tseng, MY; Turner, CL | 1 |
| Anderson, NE; Colquhoun, DM; Glasziou, P; Hankey, GJ; Hunt, D; Kirby, AC; MacMahon, S; Simes, RJ; Tonkin, AM; Watson, JD; West, MJ; White, HD | 1 |
1 review(s) available for pravastatin and Brain Ischemia
| Article | Year |
|---|---|
Neuroprotection by pravastatin in acute ischemic stroke in rats.
Topics: Animals; Anticholesteremic Agents; Brain Ischemia; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Pravastatin; Rats; Rats, Wistar; Stroke; Treatment Outcome | 2008 |
9 trial(s) available for pravastatin and Brain Ischemia
| Article | Year |
|---|---|
Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).
Topics: Aged; Aged, 80 and over; Asian People; Brain Ischemia; Carotid Intima-Media Thickness; Female; Humans; Japan; Male; Middle Aged; Pravastatin; Stroke; Time Factors | 2018 |
Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cohort Studies; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Intensive Care Units; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pravastatin; Prospective Studies; Subarachnoid Hemorrhage; Time Factors | 2014 |
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.
Topics: Aged; Asian People; Brain Ischemia; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Pravastatin; Proportional Hazards Models; Recurrence; Stroke | 2015 |
Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.
Topics: Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Male; Middle Aged; Pravastatin; Recurrence; Risk; Stroke | 2017 |
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome | 2008 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke | 2011 |
Effect of pravastatin on cerebral infarcts and white matter lesions.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cerebral Infarction; Cholesterol, LDL; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Pravastatin; Prospective Studies; Telencephalon; Treatment Failure | 2005 |
Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Aneurysm; Leukocyte Count; Lipids; Logistic Models; Middle Aged; Platelet Count; Pravastatin; Risk Factors; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Pravastatin therapy and the risk of stroke.
Topics: Adult; Aged; Anticholesteremic Agents; Brain Ischemia; Cerebral Hemorrhage; Coronary Disease; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Pravastatin; Risk Factors; Severity of Illness Index; Stroke | 2000 |
6 other study(ies) available for pravastatin and Brain Ischemia
| Article | Year |
|---|---|
Pravastatin may improve neurological outcome following low-grade aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Case-Control Studies; Cerebral Infarction; Humans; Pravastatin; Prognosis; Subarachnoid Hemorrhage; Treatment Outcome | 2022 |
Combined Treatment with Hydrophilic and Lipophilic Statins Improves Neurological Outcomes Following Experimental Cardiac Arrest in Mice.
Topics: Animals; Behavior, Animal; Blood Gas Analysis; Brain Edema; Brain Ischemia; CA1 Region, Hippocampal; Cardiopulmonary Resuscitation; Cytokines; Heart Arrest; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Neuroprotective Agents; Pravastatin; Random Allocation; Simvastatin; Survival Rate | 2020 |
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillary Permeability; Guinea Pigs; Infarction, Middle Cerebral Artery; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 3; Neuroprotective Agents; Pravastatin; Proto-Oncogene Proteins c-akt; Time Factors; Zonula Occludens-1 Protein | 2015 |
Statins and cerebral vasomotor reactivity: implications for a new therapy?
Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial | 2006 |
Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Male; Microtubule-Associated Proteins; Neurologic Examination; Neurons; Neuropeptides; Neuroprotective Agents; Phosphopyruvate Hydratase; Pravastatin; Rats; Rats, Wistar; Time Factors | 2007 |
Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Male; Pravastatin; Rats; Rats, Wistar | 2007 |